Grail

Grail

Signal active

Organization

Contact Information

Overview

Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection.

The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.

About

Industries

Biotechnology, Health Care, Medical, Medical Device, Health Diagnostics

Founded

2016

Employees

1001-5000

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Grail headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device, Health Diagnostics sector. The company focuses on Biotechnology and has secured $200.5B in funding across 100 round(s). With a team of 1001-5000 employees, Grail is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Grail, raised $100.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Scott Osler

Scott Osler

Vice President and Head of Employer Channel

imagePlace Joshua J. Ofman

Joshua J. Ofman

Chief Medical Office and External Affairs

imagePlace Jay R. Flynn, MBA, MA, PCM®-MM, PCM®-DM, CDMP, PMP®

Jay R. Flynn, MBA, MA, PCM®-MM, PCM®-DM, CDMP, PMP®

Senior Manager, Enterprise Marketing – Life Insurance Partnerships

imagePlace Aaron Freidin

Aaron Freidin

Chief Financial Officer

imagePlace Robert Ragusa

Robert Ragusa

Chief Executive Officer

Funding Rounds

Funding rounds

5

Investors

8

Lead Investors

0

Total Funding Amount

$2004.7M

Details

5

Grail has raised a total of $2004.7M in funding over 5 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2020Late Stage Venture390.0M
2016Seed
2017Early Stage Venture1214.7M
2016Early Stage Venture100.0M

Investors

Grail is funded by 31 investors.

Investor NameLead InvestorFunding RoundPartners
Biomatics Capital Partners-FUNDING ROUND - Biomatics Capital Partners100.0M
Google Ventures-FUNDING ROUND - Google Ventures100.0M
Grail-FUNDING ROUND - Grail100.0M
Longwood Fund-FUNDING ROUND - Longwood Fund100.0M

Recent Activity

There is no recent news or activity for this profile.